Logo image of CIIG

CIIG CAPITAL PARTNERS II-A (CIIG) Stock Fundamental Analysis

NASDAQ:CIIG - Nasdaq - US12561U1097 - Common Stock - Currency: USD

8.75  +0.28 (+3.31%)

After market: 9.38 +0.63 (+7.2%)

Fundamental Rating

1

Taking everything into account, CIIG scores 1 out of 10 in our fundamental rating. CIIG was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of CIIG have multiple concerns. CIIG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CIIG has reported negative net income.
CIIG had a negative operating cash flow in the past year.
CIIG Yearly Net Income VS EBIT VS OCF VS FCFCIIG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 -1M -2M -3M -4M -5M

1.2 Ratios

The profitability ratios for CIIG are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CIIG Yearly ROA, ROE, ROICCIIG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 -0.5 -1

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CIIG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CIIG Yearly Profit, Operating, Gross MarginsCIIG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, CIIG has about the same amount of shares outstanding.
The debt/assets ratio for CIIG is higher compared to a year ago.
CIIG Yearly Shares OutstandingCIIG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 10M 20M 30M
CIIG Yearly Total Debt VS Total AssetsCIIG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 50M 100M 150M 200M 250M

2.2 Solvency

CIIG has an Altman-Z score of 11.51. This indicates that CIIG is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.00 indicates that CIIG is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 11.51
ROIC/WACCN/A
WACCN/A
CIIG Yearly LT Debt VS Equity VS FCFCIIG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 0.05 indicates that CIIG may have some problems paying its short term obligations.
CIIG has a Quick Ratio of 0.05. This is a bad value and indicates that CIIG is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
CIIG Yearly Current Assets VS Current LiabilitesCIIG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 1M 2M 3M 4M 5M

More info and screens

0

3. Growth

3.1 Past

CIIG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.04%.
EPS 1Y (TTM)-13.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.52%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CIIG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CIIG Price Earnings VS Forward Price EarningsCIIG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CIIG Per share dataCIIG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CIIG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CIIG CAPITAL PARTNERS II-A

NASDAQ:CIIG (4/28/2023, 8:06:23 PM)

After market: 9.38 +0.63 (+7.2%)

8.75

+0.28 (+3.31%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.33%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap314.45M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.12
P/tB 1.12
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS7.79
TBVpS7.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z 11.51
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.52%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-254.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-62.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.03%
OCF growth 3YN/A
OCF growth 5YN/A